Abstract
Annual Review of Genetics
Vol. 39:
359-407
(Volume publication date December 2005)
(doi:10.1146/annurev.genet.39.110304.095751)
First published online as a Review in Advance on July 19, 2005A MITOCHONDRIAL PARADIGM OF METABOLIC AND DEGENERATIVE DISEASES, AGING, AND CANCER: A Dawn for Evolutionary Medicine Douglas C. Wallace Center for Molecular and Mitochondrial Medicine and Genetics, Departments of Ecology and Evolutionary Biology, Biological Chemistry, and Pediatrics, University of California, Irvine, California 92697-3940; email: dwallace@uci.edu Abstract Life is the interplay between structure and energy, yet the role of energy deficiency in human disease has been poorly explored by modern medicine. Since the mitochondria use oxidative phosphorylation (OXPHOS) to convert dietary calories into usable energy, generating reactive oxygen species (ROS) as a toxic by-product, I hypothesize that mitochondrial dysfunction plays a central role in a wide range of age-related disorders and various forms of cancer. Because mitochondrial DNA (mtDNA) is present in thousands of copies per cell and encodes essential genes for energy production, I propose that the delayed-onset and progressive course of the age-related diseases results from the accumulation of somatic mutations in the mtDNAs of post-mitotic tissues. The tissue-specific manifestations of these diseases may result from the varying energetic roles and needs of the different tissues. The variation in the individual and regional predisposition to degenerative diseases and cancer may result from the interaction of modern dietary caloric intake and ancient mitochondrial genetic polymorphisms. Therefore the mitochondria provide a direct link between our environment and our genes and the mtDNA variants that permitted our forbears to energetically adapt to their ancestral homes are influencing our health today. Acronyms ANT: adenine nucleotide translocator APP: amyloid precursor protein COX: cytochrome c oxidase, complex IV CPEO/KSS: chronic progressive external ophthalmoplegia/Kearn-Sayre syndrome CR: mtDNA control region Cu/ZnSOD (Sod1): mitochondrial intermembrane space and cytosolic superoxide dismutase ETC: mitochondrial electron transport chain, a part of the OXPHOS system FOXO: mammalian forkhead transcription factor LHON: Leber's hereditary optic neuropathy MELAS: mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes MERRF: myoclonic epilepsy and ragged red fiber disease MnSOD (Sod2): mitochondrial matrix superoxide dismutase mtDNA: mitochondrial DNA mtPTP: mitochondrial permeability transition pore NARP: neurogenic muscle weakness, ataxia, and retinitis pigmentosa OXPHOS: oxidative phosphorylation PGC-1: PPARγ (peroxisome-proliferating-activated receptor γ) coactivator 1 ROS: reactive oxygen species, oxygen radicals SDH: succinate dehydrogenase TCA: mitochondrial tricarboxylic acid cycle Unc 1,2,3: uncoupling proteins 1,2,3 Terms and Definitions Apoptosis: a process of programmed cell death resulting in the activation of caspase enzymes and intracellular nucleases that degrade the cellular proteins and nDNA. Apoptosis can be initiated via the mitochondrion through the activation of the mitochondrial permeability transition pore (mtPTP) in response to energy deficiency, increased oxidative stress, excessive Ca2+, and/or other factors Evolutionary medicine: a clinical perspective that posits that many of the common clinical problems of today are rooted in adaptive genetic programs that permitted our human ancestors to survive in the environments which they confronted in the past Mitochondrial DNA (mtDNA): the portion of the mitochondrial genome that currently resides in the matrix of the mitochondrion, as a circular DNA molecule containing the mitochondrial rRNA genes, tRNA genes, and 13 subunits of the mitochondrial oxidative phosphorylation (OXPHOS) enzyme complexes Mitochondrial medicine: the new medical discipline that pertains to all clinical problems that involve the mitochondria Mitochondrion (s), mitochondria (pl): cellular organelle of endosymbiotic origin that resides in the cytosol of most nucleated (eukaryotic) cells and which produces energy by oxidizing organic acids and fats with oxygen by the process of oxidative phosphorylation (OXPHOS) and generates oxygen radicals (reactive oxygen species, ROS) as a toxic by-product Oxidative phosphorylation (OXPHOS): the process by which the mitochondrion generates energy through oxidation of organic acids and fats with oxygen to create a capacitor [electron chemical gradient (ΔP = ΔΨ + ΔpH)] across the mitochondrial inner membrane. This ΔP is used as a source of potential energy to generate adenosine triphosphate (ATP), transport substrates or ions, or produce heat. OXPHOS encompasses five multipolypepetide complexes I, II, III, IV and V. Complex I is NADH dehydrogenase or NADH:ubiquinone oxidoreductase, complex II is succinate dehydrogenase (SDH) or succinate:ubiquinone oxidoreductase, complex III is the bc1 complex or ubiquinole:cytochrome c oxidoreductase, complex IV is cytochrome c oxidase (COX) or reduced cytochrome c: oxygen oxidoreductase, and complex V is the ATP synthase or proton-translocating ATP synthase. Complexes I, III, IV, and V encompass both nDNA- and mtDNA-encoded subunits Reactive oxygen species (ROS): primarily superoxide anion (O•-2), hydrogen peroxide (H2O2), and hydroxyl radical (•OH), commonly referred to as oxygen radicals; generated as a toxic by-product of oxidative energy production by OXPHO; which damage the mitochondrial and cellular DNA, proteins, lipids, and other molecules causing oxidative stress Most recent citing papers (via CrossRef)Role of Oxidative Stress, Apoptosis, and Intracellular Homeostasis in Primary Cultures of Rat Proximal Tubular Cells Exposed to Cadmium Biological Trace Element Research 127(1):53-68 (2009) Mitochondria as targets for cancer therapy Molecular Nutrition & Food Research 53(1):9-28 (2009) Nuclear and Mitochondrial Genome Defects in Autisms Annals of the New York Academy of Sciences 1151(1):102-132 (2009) From delocalized lipophilic cations to hypoxia: Blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors Molecular Nutrition & Food Research 53(1):68-75 (2009) Mitochondrial Haplogroups Associated with Elite Kenyan Athlete Status Medicine & Science in Sports & Exercise 41(1):123-128 (2009)
|
|
|
Users who read this review also read:
| Douglas C. Wallace Annual Review of Biochemistry. Volume 76, Page 781-821, Jul 2007 Abstract
| Full Text
| PDF (1068 KB)
|
Add to Favorites
| Related | |
| Koji Okamoto, Janet M. Shaw Annual Review of Genetics. Volume 39, Page 503-536, Dec 2005 Abstract
| Full Text
| PDF (567 KB)
|
Add to Favorites
| Related | |
| Zhengchang Liu, Ronald A. Butow Annual Review of Genetics. Volume 40, Page 159-185, Dec 2006 Abstract
| Full Text
| PDF (224 KB)
|
Add to Favorites
| Related | |
| Svante Pääbo, Hendrik Poinar, David Serre, Viviane Jaenicke-Després, Juliane Hebler, Nadin Rohland, Melanie Kuch, Johannes Krause, Linda Vigilant, Michael Hofreiter Annual Review of Genetics. Volume 38, Page 645-679, Dec 2004 Abstract
| Full Text
| PDF (228 KB)
|
Add to Favorites
| Related | |
|
|